Real-world effectiveness of osteoporosis treatment in the oldest old von Ström, O., Lauppe, R., Ljunggren, Ö., Spångéus, A., Ortsäter, G., O’Kelly, J., Åkesson, K.

Volltext

HTA82 Health Technology Assessment of Hospital Medicines in Denmark: A Review of DMC Decisions (2017-2022) von Viollet, J, O'Leary, E, Lauppe, R, Oldsberg, L, Rosenzweig, M

Volltext

428P Palbociclib dose patterns in Swedish patients with metastatic breast cancer: 5-year update from the SIRI study von Valachis, A., Lindman, H., Lauppe, R., Lilja, M., Jakobsson, M., Nyqvist, D.

Volltext

Palbociclib dose patterns in Swedish patients with metastatic breast cancer: 5-year update from the SIRI study von Valachis, A., Lindman, H., Lauppe, R., Lilja, M., Jakobsson, M., Nyqvist, D.

Volltext

POSB139 Predicting Quality of Life through Changes in Menstrual Blood Loss in Patients with Uterine Fibroids von Lilja, M, Frisell, O, Borgström, F, Geale, K, Lauppe, R

Volltext

246P Palbociclib dose patterns in Swedish patients with metastatic breast cancer: Evidence from the SIRI study von Valachis, A., Lindman, H., Fues Wahl, H., Lauppe, R., Lilja, M., Nyqvist, D., Jakobsson, M.

Volltext

HTA228 Willingness to Pay for Different Severity Levels in Sweden: An Analysis of TLV Decisions (2014-2022) von Viollet, J, O'Leary, E, Camacho Gonzalez, C, Lauppe, R, Oldsberg, L

Volltext

HTA12 Outpatient Medicine Reimbursement in Sweden: An Analysis of TLV Decisions Between 2016 and 2022 von Viollet, J, O'Leary, E, Camacho Gonzalez, C, Lauppe, R, Oldsberg, L

Volltext

Palbociclib dose patterns in Swedish patients with metastatic breast cancer: Evidence from the SIRI study von Valachis, Antonis, Lindman, H., Wahl, H. Fues, Lauppe, R., Lilja, M., Nyqvist, D., Jakobsson, M.

Volltext

PCN61 A FREELY AVAILABLE GENERIC COST-EFFECTIVENESS MODEL IN ONCOLOGY FOR EARLY-STAGE DECISION MAKING von Lauppe, R., Geale, K., Lilja, M., By, Å.

Volltext

PUK12 Using Real-World DATA to Improve the Accuracy of Economic Models; Experience from the Swedish Renal Register von Carrero, J.J., Andersson-Franko, M., Xu, Y., Lauppe, R., Lilja, M., Soro, M.

Volltext

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden von Lauppe, Rosa Elisabeth, Liseth Hansen, Johan, Gerdesköld, Christian, Rozenbaum, Mark H, Strand, Anne Mette, Vakevainen, Merja, Kuusisto, Johanna, Gude, Einar, Gustafsson, Finn, Smith, J Gustav

Volltext

PUK3 TREATMENT EFFECTS IN SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE: A SYSTEMATIC LITERATURE REVIEW von Gunnarsson, J., Lauppe, R., Widén, J., Intorcia, M., Dubois, E.M., Csomor, P.

Volltext

PUK6 A COST-EFFECTIVENESS MODEL FOR SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE von Lilja, M., Lauppe, R., Intorcia, M., Dubois, E.M., Csomor, P., Ström, O.

Volltext

POSB112 Health Care Resource Use of Transthyretin Amyloid Cardiomyopathy in Sweden von Lauppe, R, Liseth Hansen, J, Fornwall, A, Gerdesköld, C, Rozenbaum, M, Strand, A, Väkeväinen, M, Kuusisto, J, Gude, E, Gustafsson, F, Smith, JG

Volltext

PRO56 The Epidemiology of Transthyretin Amyloid Cardiomyopathy in Sweden von Lauppe, R., Liseth Hansen, J., Sandin, P., Gerdesköld, C., Rozenbaum, M.H., Strand, A., Väkeväinen, M., Kuusisto, J., Gude, E., Gustafsson, F., Smith, J.G.

Volltext

PCN191 - Costs of Grade 3 and 4 Adverse Events Associated with Current Cancer Treatments - Cost Estimations For Sweden, Norway, Finland And Denmark von Lauppe, R, Carlqvist, P, Chavez, B, Lundqvist, I, Ohna, A, Widén, J

Volltext

Costs of Grade 3 and 4 Adverse Events Associated with Current Cancer Treatments - Cost Estimations For Sweden, Norway, Finland And Denmark von Lauppe, R, Carlqvist, P, Chavez, B, Lundqvist, I, Ohna, A, Widén, J

Volltext

USING REAL-WORLD DATA TO IMPROVE THE ACCURACY OF ECONOMIC MODELS; EXPERIENCE FROM THE SWEDISH RENAL REGISTER von Carrero, JJ, Andersson-Franko, M, Xu, Y, Lauppe, R, Lilja, M, Soro, M

Volltext

A COST-EFFECTIVENESS MODEL FOR SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE von Lilja, M, Lauppe, R, Intorcia, M, Dubois, EM, Csomor, P, Strom, O

Volltext